Efficacy of RestoreX Penile Traction Therapy In Preserving Erectile Function Post-Prostatectomy
Sponsor: Charitable Union for the Research and Education of Peyronie's Disease • ClinicalTrials.gov ID: NCT05244486
Recruiting for Similar Conditions?
Sponsors are looking for patients like you. See if you qualify for compensated research studies.
Check Eligibility →Description
Evaluate the efficacy of the RestoreX penile traction device in preserving erectile function in men undergoing robotic-assisted prostatectomy. This study will evaluate men undergoing prostatectomy with bilateral nerve preservation and preserved baseline erectile function (moderate ED or better). The primary outcome will be changes in the IIEF-EFD scores between groups at 6 months. Secondary outcomes include differences in questionnaire outcomes at 3, 6, and 9 months.
Interventions
-
RestoreX 1-6 months (randomized phase)
(Device)
Study participants are recommended utilize the device for 30-60 minutes, 5-7 days a week starting at 1 month post-prostatectomy and continuing until 6 months.
-
RestoreX 6-9 months (open label phase)
(Device)
Both the treatment and control arms will be allowed to use the therapy from 6-9 months post-prostatectomy (open label phase). Only straight traction will be used (no counterbending).
Eligibility criteria
Conditions
Locations
- Mayo Clinic Arizona — Phoenix, Arizona, United States
- Northwestern University — Chicago, Illinois, United States
- University Hospital — Newark, New Jersey, United States
- The Male Fertility and Peyronie's Clinic — Orem, Utah, United States
Partner with Nurenyx
Showcase your study to thousands of motivated patients matching your criteria.
Learn MoreOfficial Source
Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
View Official Record